Disulfide bonds in non-mucin proteins and extracellular glycoproteins

Disulfide bonds in non-mucin proteins and extracellular glycoproteins represent a critical structural target for mucoactive and antioxidant therapies, particularly in the management of chronic respiratory diseases [1]. These covalent linkages are essential for maintaining the three-dimensional structure and cross-linked networks of various proteins found in respiratory secretions, including albumin, immunoglobulins, and plasma-derived glycoproteins [2]. In conditions like chronic obstructive pulmonary disease (COPD) and cystic fibrosis, the over-expression and oxidative cross-linking of these proteins contribute to the formation of hyperviscous mucus that obstructs airways and impairs mucociliary clearance [3]. Therapeutic agents such as erdosteine and N-acetylcysteine act as reducing agents by providing free thiol groups that participate in thiol-disulfide exchange reactions [1, 2]. This process breaks the disulfide bridges, effectively depolymerizing the protein network and reducing the viscosity and elasticity of the mucus to facilitate expectoration [3]. Beyond their role in mucus rheology, these bonds are vital for the stability of the extracellular matrix and various signaling molecules, making them a broad but significant pharmacological target for modulating inflammation and oxidative stress [2]. [1] Moretti, M. (2007). Erdosteine: clinical update and future perspectives. Expert Review of Respiratory Medicine. [2] Sadowska, A. M. (2012). N-Acetylcysteine as an antioxidant, a mucolytic and an anti-inflammatory drug. Expert Opinion on Drug Safety. [3] Balsamo, R., et al. (2010). Mucoactive drugs. European Respiratory Review.

Other names

Mucoprotein disulfide bondsExtracellular protein disulfide bridgesNon-mucin glycoprotein cross-linksProtein disulfide linkages

Reduction of disulfide bonds via thiol-disulfide exchange, where the drug's free sulfhydryl group reacts with the target's disulfide bridge to form a new disulfide bond with the drug and a free thiol on the protein, effectively breaking the protein cross-link.